Furthermore, consistent with in vitro results, RPS6KC1 knockdown significantly reduced tumor growth and size under Enz treatment compared to DMSO, especially when combined with Erastin (Supplement Fig. 3D-F). The gene discussed is RPS6KC1; the disease is neoplasm.